Novavax Inc
(WBO:NVAX)
€
9.276
-0.09 (-0.96%)
Market Cap: 1.49 Bil
Enterprise Value: 734.28 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 47/100 Novavax Inc at Bank of America Biotech SMID Cap Conference Transcript
Dec 07, 2022 / 02:10PM GMT
Operator
Ladies and gentlemen, the program is about to begin. Reminder that you can submit questions at any time via the ask questions tab on the webcast page. At this time, it is my pleasure to turn the program over to your host, Alec Stranahan. You may begin.
Alec Warren Stranahan
BofA Securities, Research Division - Associate
Okay. Hello, everyone. Welcome to day 1 of the 2022 Bank of America Biotech Conference. Thank you for joining this session with Novavax. My name is Alec Stranahan. I'm Vice President and Senior Biotech analyst here at BofA. And I'm pleased to be joined by John Trizzino, Chief Commercial Officer and Chief Business Officer; as well as Filip Dubovsky Executive Vice President and Chief Medical Officer. Thanks for joining guys.
John Joseph Trizzino
Novavax, Inc. - Executive VP and Chief Business & Commercial Officer
Thank you, Alec. Good to be here.
Questions & Answers
Alec Warren Stranahan
BofA Securities, Research Division - Associate
Perfect
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot